European Commission
New EU indication for Bayer and Regeneron eye drug
February 27, 2015Sales and Marketing Bayer, European Commission, Eylea, aflibercept
Bayer and Regeneron’s Eylea is now indicated for every type of the eye disease retinal vein occlusion (RVO) thanks to …
Novartis gets FDA approval for psoriasis drug
January 22, 2015Sales and Marketing Cosentyx, European Commission, FDA, Novartis, Secukinumab, psoriasis
The US Food and Drug Administration (FDA) has shown Novartis’ skin condition drug Cosentyx the green light to treat patients …
Lilly and Boehringer diabetes biosimilar sees EU approval
September 11, 2014Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly
Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …
Servier fined €331m by European Commission
July 10, 2014Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva
The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …
Can Europe really agree to speed up pricing and reimbursement?
March 6, 2012Sales and Marketing Europe, European Commission, GSK, Sir Andrew Witty, pricing and reimbursement
The European Commission has called for faster decisions to allow new medicines to enter the market faster.The Commission says the …
Misinformation charges against Servier dropped
January 30, 2012Sales and Marketing European Commission, Servier, anti-competitive behaviour
The European Commission has dropped a case against Servier in which the French manufacturer was accused of providing misleading information.The …
Europe’s €80 billion will support research
December 2, 2011Research and Development, Sales and Marketing European Commission
The European Commission has created a new €80 billion budget in an effort to encourage research and innovation across the …
Avastin’s breast cancer use to continue in Europe
March 2, 2011Sales and Marketing CHMP, Cancer, European Commission, Roche, avastin, bevacizumab, breast cancer, docetaxel, paclitaxel
Roche’s Avastin will remain on the market as a treatment for breast cancer, but only in combination with paclitaxel, the …
European Commission launches new generic deal review
January 18, 2011Sales and Marketing European Commission, anti-trust investigation, competition, generics
The European Commission has asked a number of firms to submit copies of their patent settlements in 2010 to see …
EU regulators launch fresh raids on pharma
December 7, 2010Sales and Marketing AstraZeneca, European Commission, Losec, Nexium, Nycomed, Pantazol, Ratiopharm, antitrust investigation, esomeprazole, pantoprazole
Competition regulators from the EU have raided offices of AstraZeneca and Nycomed in connection with alleged attempts to block generic …
Europe tightens patient information proposals
November 25, 2010Medical Communications, Sales and Marketing European Commission, European Parliament, dtc, patient information
European restrictions on patient access to medicines information are still on track to be relaxed, but the proposed changes have …
Digital Pharma: E-Health and the European agenda
November 19, 2010Medical Communications Digital Agenda, Digital Pharma blog, EC, European Commission, Neelie Kroes, digital patients, e-health, electronic patient records
The European Commission wants all European patients to be given secure online access to their medical records by 2015 and …
European Commission eyes pharma ethics
September 27, 2010Research and Development, Sales and Marketing European Commission, corporate responsibility, ethics
The European Commission is to examine corporate responsibility in the pharmaceutical industry with the aim of developing a series of …
European Commission invests €6.4 billion in research
July 21, 2010Research and Development European Commission, research
The European Commission has announced a €6.4 billion investment in research and innovation in a range of scientific disciplines including …
European scrutiny of pharma patent deals to continue
July 6, 2010Sales and Marketing European Commission, competition, patents
Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …
